April 2016
Regulatory Affairs Professionals Society

This article introduces the roles of HTA bodies within the EU member states healthcare system and provides key elements to consider for manufacturers, which would like to enter such geographical market, on key elements to consider. In addition solutions to maximize the product development strategy are discussed, with the intention of bridging regulatory and market access gaps.

Daniel Muscionico, PharmD, MPH, MBA, Paloma Grasser, MTIM, BSc, Rosa Mouchotte, MSc, RAC and Anne Rambaud

Access : 
Fill in the form to receive access link